#Oncology clinical trials involve a host of challenges, including the need for highly targeted therapies for specific tumor types. Read the #QPS blog to learn about solutions to oncology #clinicaltrials challenges. For more, visit https://shorturl.at/dkoN7 or email info@qps.com.
QPS Holdings, LLC’s Post
More Relevant Posts
-
As the clinical research landscapes evolve, it's important to continue evaluating trends and advancements in diagnosis and treatment. Advarra SVP of IRB Review Julie Ozier sat down with LifeSciencesIntelligence to share her insights and predictions around advancements in oncology, targeted therapies, screening & diagnosis, the future of oncology, and more. https://lnkd.in/gqEH5hTc #ClinicalResearch #ClinicalTrials #Oncology
Evaluating the Oncology Landscape: Diagnosis, Treatment, Predictions
lifesciencesintelligence.com
-
Our study examined the prevalence and characteristics of subgroup analysis in oncology clinical trials - Samer Al Hadidi https://lnkd.in/gS2AZfMy #oncodaily #oncology #cancer #research
Samer Al Hadidi: Our study examined the prevalence and characteristics of subgroup analysis in oncology clinical trials - Oncodaily | Oncology News, Insights, Stories
oncodaily.com
-
R&D, Drug Development & Medical Affairs, Market Access Global Clinical Studies and Product Marketing Lifecycle Management across the Globe
Impact of COVID-19 on oncology clinical trials #Covid19 #clinicaltrials #oncology #oncologytrials #ai #patientcentricity #globaltrials #drugdevelopment #nature #iqvia
Impact of COVID-19 on oncology clinical trials
nature.com
-
Cutting-edge approaches to patient identification and site selection are mission-critical for oncology trial success today. Dive into the data-driven strategies that leading CROs leverage. https://hubs.ly/Q02lwYWS0 #clinicalresearch #oncology #drugdevelopment
Driving Oncology Trial Execution with Novel Data-Driven Approaches to Site and Patient Identification
https://www.precisionformedicine.com
-
How is digital transformation shaping oncology? Read our article to see how new tools and strategies are addressing challenges in cancer treatment. https://hubs.la/Q02yCVRn0 #DigitalOncology #CancerResearch
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
Natalie Yeadon on LinkedIn
-
Clinical Research Associate| Protocol| Documentation| ICH GCP| Clinical Trial Monitoring, Site initiation, Close-out visits, TMF-ISF reconciliation | Cardiology, Nephrology, COVID-19, Vaccine, Neurology
Long-term collection of patient-reported outcome data in oncology trials: Important and feasible. https://lnkd.in/gRFMyNSG #clinicaltrials #oncology #patientcare
Long-term collection of patient-reported outcome data in oncology trials: Important and feasible
medicalxpress.com
-
With the large reach of #Oncology clinical trials, it’s no surprise that they often face complex enrollment and retention hurdles. Learn unique strategies to overcome these hurdles: https://bit.ly/4735qAv #CancerResearch #ClinicalTrials #ClinicalTrialTechnology
Oncology Research | Tech Solutions for Design Challenges
https://medrio.com
-
An AI-based system may reduce the time needed to match patients with cancer to suitable clinical trials. American Society of Clinical Oncology (ASCO) https://lnkd.in/e3gYnw5b #ASCO24 #cancer #oncology
Artificial Intelligence Tool May Improve Oncology Multi-Trial Matching
cancernetwork.com
-
#DidYouKnow that “sugar pills” are never used in place of standard of care in #prostatecancer clinical trials? This is a common misconception. The TAMARACK study is currently recruiting metastatic castrate-resistant prostate cancer patients and is comparing two dose levels of the same drug to evaluate effectiveness and side effects. Learn more about TAMARACK and find out if you may be eligible at https://lnkd.in/ezMpe2zr.
Clinical Trials | ZERO Prostate Cancer
https://zerocancer.org
-
Partner Content - Oncology in 2024: The clinical trial trends reshaping the role of CROs CROs are fundamental to the development of cancer treatments but face multiple challenges. Walker Bradham Product leader at Zelta by Merative analyzes the biggest trends in oncology and the technological solutions available to CROs to optimize efficiencies. - https://lnkd.in/d_FnCF5P #cro #contractresearch #oncology #dct #clinicaltrials #cancertreatments
Oncology in 2024: The clinical trial trends reshaping the role of CROs
clinicaltrialsarena.com
